HYDROPHOBIC POLYSACCHARIDES WITH DIESTER- OR CARBONATE ESTER-CONTAINING LINKAGES HAVING ENHANCED DEGRADATION
    1.
    发明申请
    HYDROPHOBIC POLYSACCHARIDES WITH DIESTER- OR CARBONATE ESTER-CONTAINING LINKAGES HAVING ENHANCED DEGRADATION 失效
    具有增强降解性的含有碳酸钙或含碳酸酯的链接的疏水性多糖

    公开(公告)号:US20100316687A1

    公开(公告)日:2010-12-16

    申请号:US12814109

    申请日:2010-06-11

    IPC分类号: A61K9/10 C07H3/06

    摘要: Hydrophobic α(1→4)glucopyranose polymers with enhanced degradation properties are described. Between the α(1→4)glucopyranose polymeric portion and the hydrophobic portion exists a linker portion having a chemistry that facilitates degradation of the polymer. Diester and carbonate ester linker chemistries are exemplified. Biodegradable matrices can be formed from these polymers, and the matrices can be used for the preparation of implantable and injectable medical devices wherein the matrix is capable of degrading in vivo at an increased rate. Matrices including and capable of releasing a bioactive agent in vivo are also described.

    摘要翻译: 描述了具有增强的降解性质的疏水性α(1→4)吡喃葡萄糖聚合物。 在α(1→4)吡喃葡萄糖聚合物部分和疏水部分之间存在具有促进聚合物降解的化学物质的接头部分。 二酯和碳酸酯接头化学品被列举。 可以由这些聚合物形成可生物降解的基质,并且该基质可用于制备可植入和可注射的医疗装置,其中基质能够以增加的速率在体内降解。 还描述了包括和能够在体内释放生物活性剂的基质。

    Hydrophobic polysaccharides with diester- or carbonate ester-containing linkages having enhanced degradation
    2.
    发明授权
    Hydrophobic polysaccharides with diester- or carbonate ester-containing linkages having enhanced degradation 失效
    疏水性多糖与含二酯或碳酸酯酯键具有增强的降解

    公开(公告)号:US08586731B2

    公开(公告)日:2013-11-19

    申请号:US12814109

    申请日:2010-06-11

    IPC分类号: C07H3/00 A61F13/00

    摘要: Hydrophobic α(1→4)glucopyranose polymers with enhanced degradation properties are described. Between the α(1→4)glucopyranose polymeric portion and the hydrophobic portion exists a linker portion having a chemistry that facilitates degradation of the polymer. Diester and carbonate ester linker chemistries are exemplified. Biodegradable matrices can be formed from these polymers, and the matrices can be used for the preparation of implantable and injectable medical devices wherein the matrix is capable of degrading in vivo at an increased rate. Matrices including and capable of releasing a bioactive agent in vivo are also described.

    摘要翻译: 描述了具有增强的降解性质的疏水性α(1-> 4)吡喃葡萄糖聚合物。 在α(1-> 4)吡喃葡萄糖聚合物部分和疏水部分之间存在具有促进聚合物降解的化学物质的连接部分。 二酯和碳酸酯接头化学品被列举。 可以由这些聚合物形成可生物降解的基质,并且该基质可用于制备可植入和可注射的医疗装置,其中基质能够以增加的速率在体内降解。 还描述了包括和能够在体内释放生物活性剂的基质。

    PHOTO-VINYL LINKING AGENTS
    6.
    发明申请
    PHOTO-VINYL LINKING AGENTS 审中-公开
    紫胶连接剂

    公开(公告)号:US20130143056A1

    公开(公告)日:2013-06-06

    申请号:US13490994

    申请日:2012-06-07

    IPC分类号: C09D4/00 C07F9/40

    摘要: Embodiments of the invention include linking agents including photo groups and vinyl groups and coatings and devices that incorporate such linking agents, along with related methods. Exemplary methods herein include methods of priming substrates and methods of coating substrates using compounds having the formula R1—X—R2, wherein R1 is a radical comprising a vinyl group, X is a radical comprising from about one to about twenty carbon atoms, and R2 is a radical comprising a photoreactive group. Embodiments herein also include linking agents having the formula R1—X—R2, wherein R1 is a radical comprising a vinyl group, X is a radical comprising from about one to about twenty carbon atoms, and R2 is a radical comprising a photoreactive group. Other embodiments are also included herein.

    摘要翻译: 本发明的实施方案包括包括光学基团和乙烯基的连接剂以及包含这种连接剂的涂层和装置以及相关方法。 本文的示例性方法包括引发底物的方法和使用具有式R1-X-R2的化合物涂覆底物的方法,其中R 1是包含乙烯基的基团,X是包含约1至约20个碳原子的基团,R 2 是包含光反应性基团的基团。 本文的实施方案还包括具有式R 1 -X-R 2的连接剂,其中R 1是包含乙烯基的基团,X是包含约1至约20个碳原子的基团,R 2是包含光反应性基团的基团。 本文还包括其它实施例。

    EMULSIONS CONTAINING ARYLBORONIC ACIDS AND MEDICAL ARTICLES MADE THEREFROM
    9.
    发明申请
    EMULSIONS CONTAINING ARYLBORONIC ACIDS AND MEDICAL ARTICLES MADE THEREFROM 失效
    含有ARYLBONONIC酸的乳液及其制品

    公开(公告)号:US20110076337A1

    公开(公告)日:2011-03-31

    申请号:US12894983

    申请日:2010-09-30

    IPC分类号: A61K9/107 A61K47/36

    摘要: The invention provides emulsion compositions that include a hydrophobic compound and an arylboronic acid. An exemplary emulsion comprises a hydrophobic polymer and a halogenated arylboronic acid. Use of an arylboronic acid provides the emulsion with exceptional stability. The stability provides advantages for the formation of articles formed from the emulsion, including microparticles, as well as other implantable or injectable medical articles having polymeric matrices.

    摘要翻译: 本发明提供了包含疏水化合物和芳基硼​​酸的乳液组合物。 示例性的乳液包含疏水性聚合物和卤代芳基硼酸。 使用芳基硼酸提供了非常稳定的乳液。 稳定性为形成由乳液形成的制品提供了优点,包括微粒,以及具有聚合物基质的其它可植入或可注射的医疗制品。

    Emulsions containing arylboronic acids and medical articles made therefrom
    10.
    发明授权
    Emulsions containing arylboronic acids and medical articles made therefrom 失效
    含有芳基硼酸的乳液和由其制成的医疗用品

    公开(公告)号:US08709489B2

    公开(公告)日:2014-04-29

    申请号:US12894983

    申请日:2010-09-30

    摘要: The invention provides emulsion compositions that include a hydrophobic compound and an arylboronic acid. An exemplary emulsion comprises a hydrophobic polymer and a halogenated arylboronic acid. Use of an arylboronic acid provides the emulsion with exceptional stability. The stability provides advantages for the formation of articles formed from the emulsion, including microparticles, as well as other implantable or injectable medical articles having polymeric matrices.

    摘要翻译: 本发明提供了包含疏水化合物和芳基硼​​酸的乳液组合物。 示例性的乳液包含疏水性聚合物和卤代芳基硼酸。 使用芳基硼酸提供了非常稳定的乳液。 稳定性为形成由乳液形成的制品提供了优点,包括微粒,以及具有聚合物基质的其它可植入或可注射的医疗制品。